Want to see STLN full AI Analyst Report?
Starling Oncology Institute (STLN) Ownership Overview
21.39% Insiders
7.06% Mutual Funds
0.22% Other Institutional Investors
9.08% ETFs
62.24% Public Companies and
Individual Investors
The ownership structure of Starling Oncology Institute (STLN) stock is a mix of institutional, retail, and individual investors. Approximately 16.36% of the company’s stock is owned by Institutional Investors, 21.39% is owned by Insiders, and 62.24% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 24, 2026 | xxxxxxxxxxxxx | $1945533 | |
Aug 17, 2026 | xxxxxxxxxxxxx | $78480 | |
Jul 22, 2026 | xxxxxxxxxxxxx | $94860 | |
Jul 16, 2026 | xxxxxxxxxxxxx | $150178 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $244198 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,660,858 | Insider | 10.66% | 67,056,797 | |
| 5,444,207 | Insider | 5.45% | 34,244,062 | |
| 4,448,370 | Institution | 4.45% | 27,980,247 | |
| 3,384,687 | Institution | 3.39% | 21,289,681 | |
| 3,360,052 | Institution | 3.36% | 21,134,727 | |
| 2,938,751 | Institution | 2.94% | 18,484,744 | |
| 2,337,166 | Insider | 2.34% | 14,700,774 | |
| 1,711,323 | Institution | 1.71% | 10,764,222 | |
| 878,231 | Institution | 0.88% | 5,524,073 | |
| 859,809 | Institution | 0.86% | 5,408,199 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,384,687 | Institution | 3.39% | 21,289,681 | |
| 878,231 | Institution | 0.88% | 5,524,073 | |
| 859,809 | Institution | 0.86% | 5,408,199 | |
| 695,195 | Institution | 0.70% | 4,372,777 | |
| 406,094 | Institution | 0.41% | 2,554,331 | |
| 214,890 | Institution | 0.21% | 1,351,658 | |
| 127,510 | Institution | 0.13% | 802,038 | |
| 95,264 | Institution | 0.10% | 599,211 | |
| 49,126 | Institution | 0.05% | 309,003 | |
| 42,968 | Institution | 0.04% | 270,269 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,395,214 | Institution | 2.40% | 15,137,752 | |
| 1,951,341 | Institution | 1.95% | 12,273,935 | |
| 1,000,418 | Institution | 1.00% | 6,322,642 | |
| 554,956 | Institution | 0.56% | 3,490,673 | |
| 500,014 | Institution | 0.50% | 3,355,094 | |
| 444,696 | Institution | 0.44% | 2,810,479 | |
| 401,031 | Institution | 0.40% | 2,690,918 | |
| 316,217 | Institution | 0.32% | 2,121,816 | |
| 233,356 | Institution | 0.23% | 1,467,809 | |
| 228,957 | Institution | 0.23% | 1,440,140 |
FAQ
Who Owns Starling Oncology Institute (STLN)?
According to the latest TipRanks data, approximately 0.22% of the company's stock is held by institutional investors, 21.39% is held by insiders, and 62.24% is held by retail investors.
What percentage of Starling Oncology Institute (STLN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.22% of Starling Oncology Institute (STLN) stock is held by institutional investors.
What percentage of Starling Oncology Institute (STLN) stock is held by retail investors?
According to the latest TipRanks data, approximately 62.24% of Starling Oncology Institute (STLN) stock is held by retail investors.
Who owns the most shares of Starling Oncology Institute (STLN)?
Chernett Jorey owns the most shares of Starling Oncology Institute (STLN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.